|Articles|October 2, 2022
- Pharmaceutical Technology, October 2022
- Volume 46
- Issue 10
- Pages: 12
Next-Generation Synthetic Biology Workflow Platform
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences. Designed for use with synthetic biology workflows, the system provides overnight, automated synthesis of genes, clones, DNA libraries, and mRNA. It is capable of processing up to 96 gene fragments overnight.
The system features a unique instrument design that is intended to minimize benchtop footprint while also increasing throughput and versatility. Proprietary error correction and Gibson assembly technology automate the identification and removal of mismatches introduced during synthesis and assembly.
Articles in this issue
over 3 years ago
Adopting Smart Development Strategiesover 3 years ago
Reformulating Successover 3 years ago
Analyzing Extractables and Leachables in Single-Use Systemsover 3 years ago
Improving Sterility Using Blow-Fill-Seal Technologyover 3 years ago
Electrochemistry for API Synthesisover 3 years ago
Shining a Light on Lipid Nanoparticle Characterizationover 3 years ago
The Future of Drug Delivery for Biopharmaceuticalsover 3 years ago
The State of Contamination Controlover 3 years ago
Biologic Standards in the Pharmacopoeias: An UpdateNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
Single-Use Systems Enable Commercial-Scale CGT Manufacturing
4
Pharmaceutical Supply Chain Resilience in a Shifting Market
5